{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T11:23:55Z","timestamp":1792754635878,"version":"4.5.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1681\/asn.2013040430","type":"journal-article","created":{"date-parts":[[2014,3,7]],"date-time":"2014-03-07T23:36:50Z","timestamp":1394235410000},"page":"1357-1366","source":"Crossref","is-referenced-by-count":321,"title":["Phospholipase A2 Receptor Autoantibodies and Clinical Outcome in Patients with Primary Membranous Nephropathy"],"prefix":"10.1681","volume":"25","author":[{"given":"Elion","family":"Hoxha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunther","family":"Zahner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Panzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Harendza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf A.K.","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-26-20230208","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"R2-26-20230208","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM199307083290203","article-title":"Prognosis of untreated patients with idiopathic membranous nephropathy.","volume":"329","author":"Schieppati","year":"1993","journal-title":"N Engl J Med"},{"key":"R3-26-20230208","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1681\/ASN.2009080861","article-title":"Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy.","volume":"21","author":"Polanco","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R4-26-20230208","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/ki.1997.127","article-title":"Validation of a predictive model of idiopathic membranous nephropathy: Its clinical and research implications.","volume":"51","author":"Cattran","year":"1997","journal-title":"Kidney Int"},{"key":"R5-26-20230208","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.2215\/CJN.00670112","article-title":"Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy.","volume":"7","author":"van den Brand","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R6-26-20230208","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1093\/ndt\/gfr247","article-title":"An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis.","volume":"26","author":"Hoxha","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R7-26-20230208","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.2012030242","article-title":"Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy.","volume":"23","author":"Hofstra","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R8-26-20230208","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cca.2013.03.015","article-title":"Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy.","volume":"421","author":"D\u00e4hnrich","year":"2013","journal-title":"Clin Chim Acta"},{"key":"R9-26-20230208","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1681\/ASN.2010111125","article-title":"Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy.","volume":"22","author":"Beck","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R10-26-20230208","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMc1003066","article-title":"PLA2R autoantibodies and recurrent membranous nephropathy after transplantation.","volume":"363","author":"Stahl","year":"2010","journal-title":"N Engl J Med"},{"key":"R11-26-20230208","first-page":"203","article-title":"Urinary excretion of the C5b-9 membrane attack complex of complement is a marker of immune disease activity in autologous immune complex nephritis.","volume":"138","author":"Pruchno","year":"1991","journal-title":"Am J Pathol"},{"key":"R12-26-20230208","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1172\/JCI109837","article-title":"Experimental membranous glomerulonephritis in rats. Quantitative studies of glomerular immune deposit formation in isolated glomeruli and whole animals.","volume":"66","author":"Salant","year":"1980","journal-title":"J Clin Invest"},{"key":"R13-26-20230208","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ki.2012.486","article-title":"Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy.","volume":"83","author":"Kanigicherla","year":"2013","journal-title":"Kidney Int"},{"key":"R14-26-20230208","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1681\/ASN.V93444","article-title":"A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.","volume":"9","author":"Ponticelli","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"R15-26-20230208","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/ki.1995.161","article-title":"A controlled trial of cyclosporine in patients with progressive membranous nephropathy.","volume":"47","author":"Cattran","year":"1995","journal-title":"Kidney Int"},{"key":"R16-26-20230208","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1681\/ASN.2012020181","article-title":"Rituximab in idiopathic membranous nephropathy.","volume":"23","author":"Ruggenenti","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R17-26-20230208","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nm.1857","article-title":"The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.","volume":"14","author":"Faul","year":"2008","journal-title":"Nat Med"},{"key":"R18-26-20230208","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1681\/ASN.2012060602","article-title":"Rituximab in membranous nephropathy: Is it a first-line treatment?","volume":"23","author":"Appel","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R19-26-20230208","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1681\/ASN.2012010058","article-title":"Treatment of idiopathic membranous nephropathy.","volume":"23","author":"Waldman","year":"2012","journal-title":"J Am Soc Nephrol"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201406000-00026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:23:56Z","timestamp":1786130636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201406000-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2013040430","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718304585.793499447","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718304585.793493734","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718304585.793497462","asserted-by":"object"}]},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}